I expect JnJ getting hit by the huge recall costs (90,000 devices + the lost marketing spend/profit/sales + replacement costs) with their “Veiro IQ” smart blood sugar monitor will accelerate interest in mobile connectivity so that in future a medical device plagued by a gremlin like this can be remedied with a simple over the air update.

As we expect more intelligence in our ever smarter medical devices it’s increasingly unsustainable for them to remain disconnected even if that does throw medical device brands directly into the line of sight of the “Cannibal of Cannibals!”

Time is passing quickly for Medical Device brands who want to survive past 2020: